Trial · NCT00385138
Registered outcomes20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 20
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of All-cause Mortality, Myocardial Infarction (MI), and Ischemia-driven Revascularization (IDR) | randomization through 48 hours post randomization | mITT population; (composite incidence) |
| Secondary | Incidence of All-cause Mortality or MI | randomization through 48 hours post randomization | mITT population |
| Secondary | Incidence of All-cause Mortality | randomization through 48 hours post randomization | mITT population |
| Secondary | Incidence of MI | randomization through 48 hours post randomization | mITT population |
| Secondary | Incidence of IDR | randomization through 48 hours post randomization | mITT population |
| Secondary | Incidence of Stent Thrombosis | randomization through 48 hours post randomization | mITT population |
| Secondary | Incidence of Stroke | randomization through 48 hours post randomization | mITT |
| Secondary | Incidence of All-cause Mortality | randomization through 1 year post randomization | mITT population |
| Secondary | Incidence of Procedure Events [Abrupt Closure, Threatened Abrupt Closure, Need for Urgent Coronary Artery Bypass Graft (CABG) Surgery, Unsuccessful Procedure, New Thrombus or Suspected Thrombus, and/or Acute Stent Thrombosis] | During index PCI | mITT population A patient could have multiple procedural events. |
| Secondary | Incidence of GUSTO Severe / Life-threatening | randomization through 48 hours post randomization | Major bleeding (non-CABG-related) - Safety population |
| Secondary | Incidence of Thrombolysis in Myocardial Infarction (TIMI) Major | randomization through 48 hours post randomization | Major bleeding (non-CABG-related) - Safety population |
| Secondary | Incidence of ACUITY Major Bleeding | randomization through 48 hours post randomization | Major bleeding (non-CABG-related) - Safety population |
| Secondary | Incidence of ACUITY Major Bleeding Without Hematoma >/= 5 cm | randomization through 48 hours post randomization | Major bleeding (non-CABG-related) - Safety population excludes ACUITY major bleeding for which the only qualifying event was hematoma \>/= 5 cm. |
| Secondary | Incidence of All-cause Mortality, MI, or IDR | randomization through 30 days post randomization | mITT population |
| Secondary | Incidence of All-cause Mortality or MI | randomization through 30 days post randomization | mITT population |
| Secondary | Incidence of All-cause Mortality | randomization through 30 days post randomization | mITT population |
| Secondary | Incidence of MI | randomization through 30 days post randomization | mITT population |
| Secondary | Incidence of IDR | randomization through 30 days post randomization | mITT population |
| Secondary | Incidence of Stent Thrombosis | randomization through 30 days post randomization | mITT population |
| Secondary | Incidence of Stroke | randomization through 30 days post randomization | mITT population |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00385138/registered